iLCT Pipeline Research Acceleration Programme
This programme funds research that has been outlined by our iLCT committee to be necessary before a therapy can move into clinical trials for Parkinson’s.
We have now opened our first call for 2026 and are welcoming applications until Tuesday 7 April.
Q&A Sessions
We will be hosting two optional Q&A sessions to provide potential applicants with more information about the funding call and project ahead of the deadline. These will take place at 4pm (GMT) Monday 23 February and 11am (GMT) Thursday 26 March.
To attend, please sign up below.
iLCT Pipeline FAQ
See a summary of the questions discussed during the Q&A sessions.
Background
Each year, the International Linked Clinical Trials (iLCT) Committee, which comprises a panel of world-leading Parkinson’s experts, meet to evaluate a set of detailed dossiers prepared by the Cure Parkinson’s Research Team. The dossiers provide information about therapies with the potential to modify the progression of Parkinson’s. The committee evaluate and rank the candidates, with the highest ranking drugs becoming prioritised for clinical testing in people with Parkinson’s. Sometimes, there are drugs that the committee regards as showing great potential but require further research before being tested in people with Parkinson’s.
These drugs become candidates for the iLCT Pipeline Research Acceleration Programme, a funding call set up by Cure Parkinson’s to accelerate the additional research required for agents to move forward into clinical testing in people with Parkinson’s. The type of research covered by this programme may include preclinical, epidemiological, dose-finding, or target engagement research.
The application process and how to apply
Twice a year, this programme will for open for applications for funding based on specific project outlines developed by Cure Parkinson’s. This will be to test one therapy that has been evaluated by the iLCT committee and will based on their feedback.
These project outlines will include details such as:
- The therapy to be tested
- The models to be used
- Any specific assessments to be included
- Maximum project cost
- Maximum project duration
- Key funding call dates
Those interested in applying should complete the application form, detailed budget template and commercial entity form (if applicable) and send to research@cureparkinsons.org.uk by the deadline below.
Please note, due to the specificity of this call, no more than three applications will be sent for external peer review before being evaluated by Cure Parkinson’s independent Research Committee. Following evaluation, a maximum of one application will be recommended to Cure Parkinson’s Trustees for funding, subject to the Research Committee deeming the application fundable.
For further information about this funding programme, please refer to the applicant guidance below or email research@cureparkinsons.org.uk.
Key dates
Call opens: Monday 9 February
Q&A session 1: Monday 23 February, 4pm (GMT)
Q&A session 2: Thursday 26 March, 11am (GMT)
Application deadline: Tuesday 7 April, 11:59pm (BST)
Anticipated result: August 2026
